AlphaYouRI
Insider selling
Robert Iannone sold $19.2M of Jazz Pharmaceuticals plc (JAZZ) stock
Robert Iannone, EVP, Global Head of R&D & CMO of Jazz Pharmaceuticals plc (JAZZ), sold 76,921 shares of JAZZ stock worth $19.2M, per an SEC Form 4 filed Aug 31, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Aug 27, 2026, 4 days before it was made public.
JAZZ has moved -3.8% since the trade date, from $251.10 to $241.46 (Sep 21, 2026 close).
- Traded
- Aug 27, 2026
- Disclosed
- Aug 31, 2026
- Filing delay
- 4 days
- Price since
- -3.8%
- Role
- EVP, Global Head of R&D & CMO
- Source
- SEC Form 4
More JAZZ insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.